for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Astrazeneca Pharma India Ltd

ASTR.NS

Latest Trade

3,436.25INR

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

1,885.00

 - 

4,970.00

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Latest Developments

Astrazeneca Pharma India Dec-Quarter PAT Falls

Feb 8 (Reuters) - Astrazeneca Pharma India Ltd <ASTR.NS>::ASTRAZENECA PHARMA INDIA DEC-QUARTER PAT 210.5 MILLION RUPEES VERSUS PROFIT 267 MILLION RUPEES YEAR AGO.ASTRAZENECA PHARMA INDIA DEC-QUARTER REVENUE FROM OPERATIONS 2 BILLION RUPEES VERSUS 2.24 BILLION RUPEES YEAR AGO.

Astrazeneca Pharma India Sept-Quarter Profit Rises

Nov 5 (Reuters) - Astrazeneca Pharma India Ltd <ASTR.NS>::ASTRAZENECA PHARMA INDIA SEPT-QUARTER PAT 263.4 MILLION RUPEES VERSUS 144.2 MILLION RUPEES.ASTRAZENECA PHARMA INDIA SEPT-QUARTER REVENUE FROM OPERATIONS 2.09 BILLION RUPEES VERSUS 2.08 BILLION RUPEES.

Astrazeneca Pharma India Commences Launch Of QTERN In India

Feb 20 (Reuters) - Astrazeneca Pharma India Ltd <ASTR.NS>::ASTRAZENECA PHARMA INDIA - COMMENCED LAUNCH OF FDC OF DAPAGLIFLOZIN 10MG + SAXAGLIPTIN 5MG FILM COATED TABLETS IN INDIA.

Astrazeneca Pharma India Dec-Quarter Profit Falls

Feb 3 (Reuters) - Astrazeneca Pharma India Ltd <ASTR.NS>::DEC-QUARTER PROFIT 267 MILLION RUPEES VERSUS 290.9 MILLION RUPEES YEAR AGO.DEC-QUARTER REVENUE FROM OPERATIONS 2.24 BILLION RUPEES VERSUS 2.15 BILLION RUPEES YEAR AGO.

Astrazeneca Pharma India Sept Quarter Profit Rises

Nov 11 (Reuters) - Astrazeneca Pharma India Ltd <ASTR.NS>::SEPT QUARTER PROFIT 144.2 MILLION RUPEES VERSUS PROFIT OF 91.3 MILLION RUPEES YEAR AGO.SEPT QUARTER REVENUE FROM OPERATIONS 2.08 BILLION RUPEES VERSUS 1.61 BILLION RUPEES YEAR AGO.

Astrazeneca Pharma India Gets Import, Market Permission For Dapagliflozin + Saxagliptin Film Coated Tablets

Sept 25 (Reuters) - Astrazeneca Pharma India Ltd <ASTR.NS>::GETS IMPORT AND MARKET PERMISSION IN FORM 45 FROM DCGI FOR FDC OF DAPAGLIFLOZIN 10MG + SAXAGLIPTIN 5MG FILM COATED TABLETS.

Bioton Books Impairment Loss To Affect Its H1 Net Result

Sept 25 (Reuters) - Bioton SA <BIOP.WA>::RESOLVES TO BOOK IMPAIRMENT LOSS WHICH WILL AFFECT H1 CONSOLIDATED NET RESULT BY 100.7 MILLION ZLOTYS.SAID IMPAIRMENT LOSS REGARDS UPDATED VALUE OF COMPANY'S ASSETS IN ITS UNIT BIOLEK.

Astrazeneca Pharma India June-Qtr Profit Rises

Aug 7 (Reuters) - Astrazeneca Pharma India Ltd <ASTR.NS>::JUNE QUARTER PROFIT 215.2 MILLION RUPEES VERSUS PROFIT OF 63.9 MILLION RUPEES LAST YEAR.JUNE QUARTER REVENUE FROM OPERATIONS 2.05 BILLION RUPEES VERSUS 1.61 BILLION RUPEES LAST YEAR.

Astrazeneca Pharma India March-Qtr Profit Rises

May 24 (Reuters) - Astrazeneca Pharma India Ltd <ASTR.NS>::MARCH QUARTER PROFIT 98.2 MILLION RUPEES VERSUS PROFIT OF 32.2 MILLION RUPEES LAST YEAR.MARCH QUARTER REVENUE FROM OPERATIONS 1.90 BILLION RUPEES VERSUS 1.51 BILLION RUPEES LAST YEAR.

Astrazeneca Pharma India Posts Dec Qtr Profit

Feb 6 (Reuters) - Astrazeneca Pharma India Ltd <ASTR.NS>::DEC QUARTER PROFIT 290.9 MILLION RUPEES VERSUS LOSS OF 103.5 MILLION RUPEES LAST YEAR.DEC QUARTER REVENUE FROM OPERATIONS 2.15 BILLION RUPEES VERSUS 1.29 BILLION RUPEES LAST YEAR.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up